Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factorial phase 3 study of MK-0524B combination tablet in primary hypercholesterolemia or mixed hyperlipidemia
2005-005094-30Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypercholesterolemia and combined dyslipidaemia comparing MK-0524B, MK-0524A and Simvastatin (3 arms). Started Dec 2005; status: completed.
02
Drugs
Niacin + laropiprant + simvastatinlaropiprant + niacinsimvastatin
03
Conditions
hypercholesterolemiacombined dyslipidaemia
Beyond the preview
Go deeper on 2005-005094-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005094-30.